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Histopathology images are im-
portant for cancer diagnosis and
prognosis. We extracted quanti-
tative morphological features
from breast cancers images and
systematically analyzed their re-
lationships with proteins and
mRNAs. We observed concord-
ant correlation patterns between
image-protein and image-RNA
and identified four cancer-re-
lated biological processes asso-
ciated with morphological fea-
tures related to different tumor
components. Further, we ob-
served that proteomic data re-
veal unique protein-related bio-
logical processes associated
with morphology. Finally, prog-
nostic morphological features
were identified, and their roles




• Consistent correlation patterns between image-protein and image-mRNA at genome level.
• Four major biological processes associated with cellular and tissue morphology.
• Proteomic data reveal protein-specific biology processes associated with morphology.
• Morphological features can predict survival with relevant molecular events.
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Tumors are heterogeneous tissues with different types
of cells such as cancer cells, fibroblasts, and lympho-
cytes. Although the morphological features of tumors
are critical for cancer diagnosis and prognosis, the un-
derlying molecular events and genes for tumor morphol-
ogy are far from being clear. With the advancement in
computational pathology and accumulation of large
amount of cancer samples with matched molecular and
histopathology data, researchers can carry out integra-
tive analysis to investigate this issue. In this study, we
systematically examine the relationships between mor-
phological features and various molecular data in breast
cancers. Specifically, we identified 73 breast cancer pa-
tients from the TCGA and CPTAC projects matched
whole slide images, RNA-seq, and proteomic data. By
calculating 100 different morphological features and
correlating them with the transcriptomic and proteomic
data, we inferred four major biological processes asso-
ciated with various interpretable morphological fea-
tures. These processes include metabolism, cell cycle,
immune response, and extracellular matrix development,
which are all hallmarks of cancers and the associated mor-
phological features are related to area, density, and shapes
of epithelial cells, fibroblasts, and lymphocytes. In addition,
protein specific biological processes were inferred solely
from proteomic data, suggesting the importance of pro-
teomic data in obtaining a holistic understanding of the
molecular basis for tumor tissue morphology. Furthermore,
survival analysis yielded specific morphological features
related to patient prognosis, which have a strong asso-
ciation with important molecular events based on our
analysis. Overall, our study demonstrated the power for
integrating multiple types of biological data for cancer
samples in generating new hypothesis as well as iden-
tifying potential biomarkers predicting patient outcome.
Future work includes causal analysis to identify key
regulators for cancer tissue development and vali-
dating the findings using more independent data
sets. Molecular & Cellular Proteomics 18: S37–S51,
2019. DOI: 10.1074/mcp.RA118.001232.
The aggregation of large amount of trans-omics data in-
cluding high-throughput genetic, transcriptomic, proteomic
and clinical information has revolutionized disease research in
the past decade but also led to a series of new analytical
challenges, calling for new approaches and solutions that aim
at improving diagnosis, prognosis, and treatment of complex
diseases (1–5). Cancer is a disease with complex underlying
molecular mechanisms and factors, and researchers have
contributed an overwhelmingly large body of data to charac-
terize, diagnose, and ultimately treat patients with greater
precision (6–8). This data revolution enabled researchers to
identify genetic mutations and gene expression signatures
associated with the development of cancers (6, 9, 10). How-
ever, despite these considerable progresses in understanding
cancer at multiple levels of biological events, a substantial
challenge is to link different types of data with cancer cell and
tissue morphology, with the latter being essential for diagno-
sis and prognosis in clinical practice.
Solid tumors are heterogeneous tissues that contain a mix-
ture of malignant and non-malignant cells, such as stromal
cells and lymphocytes (11, 12). Distinct molecular differences
exist for cells derived from different tissues, reflected in dif-
ferent patterns in multi-omics data including gene and protein
expression profiles (9, 13). These molecular differences, in
turn, induce changes in biological functions and morphology
of tumor tissue and cells, which are often associated with
different prognosis of cancers (14). To date, many studies
have addressed the close relationship between molecular
events and morphological features of tumor tissues. For in-
stance, Baba et al. (15) systematically discussed the associ-
ation between mitoses and metabolism with nuclear changes
and Wang et al. (16) identified genes whose expression levels
are associated with multiple morphological features of tumor
cells in triple negative breast cancer. Although remarkable
achievements have been made, there are still many important
questions to be answered. For example, what is the underly-
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ing molecular basis for the cellular and tissue heterogeneity in
the tumor (17)? How are the transcriptional and proteomic
aberrations reflected on cellular morphology? Therefore,
studying the correlations between nuclear morphology and
molecular data, especially functional data including both tran-
scriptomic and proteomic data will shed light on the molecular
basis of various morphological features of cells and tissues,
addressing important questions in cancer development.
Pathological diagnosis is critical for clinical oncology where
morphological features are extensively used for diagnostics
and prognosis (18). Histopathology images derived from he-
matoxylin and eosin (H&E)-stained cancer tissue slide contain
information regarding morphology (e.g. nuclear area, nuclear
shape) and spatial context (e.g. cell density) of diverse types
of cells coexisting in the tumor microenvironment (12, 14, 19).
Although our previous work (16, 20, 21) along with many work
by others (17, 19, 22, 23) have successfully demonstrated a
connection between cellular and tissue morphology and clin-
ical outcome for cancers, the underlying molecular basis es-
pecially key biological processes associated with these mor-
phological features have not been well understood. Therefore,
investigating the biological processes underlying the prog-
nostic morphological features is an important issue in cancer
biology and outcome prediction.
To address these issues, matched histopathology images
and multi-omics datasets for cancers are required. Fortu-
nately, large consortium endeavors, such as The Cancer Ge-
nome Atlas (TCGA)1 have accumulated many large datasets
to enable such analyses. TCGA aggregates an extensive col-
lection of omics and clinical datasets from large cohorts of
patients for more than 30 types of cancers (24). It also ar-
chives histopathology images for solid tumor samples from
which omics data were sampled. Currently, more than 24,000
histopathology images are available and can be visualized
at the Cancer Digital Slide Archive (CDSA, http://cancer.
digitalslidearchive.net/). In addition, The NCI Clinical Proteomic
Tumor Analysis Consortium (CPTAC) (https://proteomics.
cancer.gov/programs/cptac) program also provides high-
throughput proteomic data for some of the TCGA tumor spec-
imens such as breast cancer, ovarian cancer, and colorectal
cancer based on mass-spectrometry technology. These
large-scale experimental datasets make comprehensive inte-
grative and correlative analyses feasible.
In this study we aim to systematic explore the relationship
among molecular, morphological, and clinical data for differ-
ential cell types in breast cancer. Previously, we developed a
quantitative image analysis pipeline that automatically ex-
tracts quantitative cellular morphological features such as
nuclear size, nuclear shape, and cell density from H&E-
stained whole-slide images (25). Based on this pipeline we
performed a series of analysis correlating and integrating
molecular data, morphological features, and clinical outcome
using data from TCGA and CPTAC Breast invasive carcinoma
(BRCA) project. Breast cancer is one of the most common
malignant cancers (25) and matched histopathology images
and omics data including the genome-wide proteomic, tran-
scriptomic, and Reverse Phase Protein Array (RPPA) pro-
teomic data were acquired from CPTAC and TCGA for a
subset of 73 patients in BRCA (25, 26). First, we performed a
correlative analysis between multi-omics data (including pro-
teomic, transcriptomics data) and morphological features ex-
tracted from histopathology images. We observed that pro-
teomic and transcriptomic data shared consistent correlation
pattern with various morphological features at genome scale.
However, comparing to transcriptomics data, proteomic data
can identify specific protein-related biological processes as-
sociated with morphological features that otherwise cannot
be inferred from transcriptomic data. More comprehensive
analysis revealed that four major categories of biology pro-
cesses related to the hallmarks of cancer (6) are associated
with different morphological feature based on the correlated
proteomic data. Furthermore, we examined the relationship
between nuclear morphology and patient outcome (i.e. sur-
vival time). Both prognostically favorable and unfavorable
morphological features have been identified. The biological
processes associated with these prognostic morphological
features were also identified based on proteomic data. The
biological processes such as immune responses, cell cycle,
and extracellular matrix development have been previously
associated with cancer patient outcome. In summary, our
work linked molecular data, morphology, and clinical out-
come, which led to new insights and hypotheses into the
relationships between cancer tissue development and molec-
ular events, thus contributing to a more comprehensive un-
derstanding of breast cancer. The entire process and work-
flow can be applied to other cancers.
EXPERIMENTAL PROCEDURES
Experimental Design and Statistical Rationale—The main objective
of this study is to explore the relationship between molecular data and
tumor morphology. Firstly, we performed correlation analysis be-
tween molecular data (i.e. mRNA-seq data from TCGA and proteomic
data from CPTAC respectively) and quantitative morphological fea-
tures extracted from histopathology images of breast cancers. We
examined the distribution patterns of correlation coefficients between
image-mRNA and image-protein pairs at genome scale. Secondly, we
validated the above distribution patterns of correlation coefficients
using proteomic data generated from the RPPA technology and mor-
phological features. Thirdly, we compared the biological processes
associated with morphological and spatial features based on the
strongly correlated mRNAs and proteins. Finally, we summarized the
major biological implications underlying the various morphological
features. In addition to the correlation analysis, we explored the
relationships among morphology, patient outcome, and the underly-
ing biological processes derived from protein data.
1 The abbreviations used are: TCGA, The Cancer Genome Atlas;
CPTAC, Clinical Proteomic Tumor Analysis Consortium; RPPA, re-
verse phase protein array; TME, tumor microenvironment; GO, Gene
ontology; BP, biological process; ECM, extracellular matrix; MRPs,
mitochondrial ribosomal proteins.
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The overall workflow for the analysis is summarized in Fig. 1 with
the correlation and other bioinformatics analyses outlined in Fig. 1B.
For nuclear morphology-proteomic-transcriptomic correlation analy-
sis, we identified a set of 73 patients whose tumor samples are shared
by the TCGA BRAC project and CPTAC breast cancer project with
matched H&E-stained whole-slide images, MS-derived proteomic
profiles, and RNA-seq transcriptomic data. Specifically, the CPTAC
consortium contained 105 breast cancer proteome profiles, of which
77 samples contained non-degraded data (26) that include the 73
selected samples. Proteomic data were accessed and downloaded
using the R package “TCGA-Assembler 2” (27, 28) from the CPTAC.
Histopathology images were downloaded directly through the GDC
FIG. 1. Study workflow: A, Tissue morphological feature extraction pipeline. B, Schematic diagram for correlation analysis among mRNA,
protein abundance, morphology, and clinical prognosis. (Abbreviations: Area: nuclear area; Major_Axis: length major axis of nuclear;
Minor_Axis: length of minor axis of a nuclear; Ratio: the ratio between lengths of major and minor axes; Mean_Distance: mean distance to
neighboring cells; Max_Distance: maximum distance to neighboring cells; Min_Distance: minimum distance to neighboring cells.)
Correlative Analysis of Proteomic and Image Data for BRCA
Molecular & Cellular Proteomics 18.14 S39
TCGA Data Portal, whereas transcriptomic data were downloaded
from the UCSC Xena data portal (https://xena.ucsc.edu/public-hubs/)
(29). To validate correlation analysis between proteomic and tran-
scriptomic profiles for genes, matched RPPA proteomic data were
obtained for each of the 73 samples described above from the Broad
GDAC Firehose (https://gdac.broadinstitute.org). The RPPA dataset
contains protein expression profiles for 183 genes instead of the
entire genome.
To understand the relationship between image analysis-derived
cell morphological features and patient survival outcomes, 1,057
BRCA-type breast patients with matched 1057 H&E-stained tissue
images and corresponding clinical survival information were used.
The patient clinical data were obtained from UCSC Xena. Demo-
graphic and clinical characteristics of the patients were described in
Table I.
Analysis of Nuclear Morphology from Archived Histopathology Im-
ages—As outlined in Fig. 1A, using our previously developed image
analysis algorithms and pipeline (30, 31), automated image analysis
was carried out and ten types of cell-level features from tissue images
were extracted following the three main steps: 1) nuclei segmentation,
2) cell-level feature measurement, and 3) aggregation of cell-level
measurements into patient-level statistics. In Step 1, the nuclei of all
cells in the image are automatically segmented based on our previous
workflow (31). In Step 2, ten types of cell-level features were ex-
tracted, including seven types of morphological and spatial traits and
three types of pixel traits in the RGB color space. The seven types of
morphological and spatial features of cell nuclei were: major axis
length (Major_Axis), minor axis length (Minor_Axis), the ratio of major
to minor axis length (Ratio), nuclear area (Area), mean distance to
neighboring cells (Mean_Distance), maximum distance to neighboring
cells (Max_Distance), and minimum distance to neighboring cells
(Min_Distance). The seven types of morphological and spatial fea-
tures of cell nuclei can be summarized as nucleic area (Area), nucleic
shape (Major_Axis, Minor_Axis, and Ratio), and cell density (Mean_
Distance, Max_Distance and Min_Distance). In Step 3, 5-bin histo-
gram and five distribution statistics (i.e. mean, standard deviation or
S.D., skewness, kurtosis, and entropy) were calculated for each of the
ten types of morphological features to aggregate the measurements
over the whole slide image. Thus for each type of feature, ten meas-
urements (i.e. five histogram bins and five distribution statistics) were
generated and 100 image features were generated in total for the ten
types of morphological features. The centers of the five bins were
determined by clustering each type of cell-level features from all
patients instead of a single patient, which ensured that the histogram
features are comparable and consistent across the entire patient
cohort. The value of each feature based on the five bins of the
histogram represented the relative percentage of corresponding im-
age feature over the entire slide for a patient.
To identify distinctive features among the morphological and spa-
tial features, we focused our analysis on the smallest and largest ends
of the morphological features for seven types cell-type image fea-
tures. We designated these features with intuitive names such as
Small_Nucleus_Area and Large_Nucleus_Area. The Small_Nucleus_
Area is the first bin of the five-bin histogram, thus representing the
proportion of very small nuclei. Other feature names are similarly
defined. The visual explanation of these morphological features and
putative biological interpretations can be found in Table II.
Analysis of MS-based Proteomic Data—We obtained log2-trans-
formed iTRAQ values of protein abundance from CPTAC. The iTRAQ
values were calculated as the log2-transformed ratio of spectral
counts of target proteins versus a reference. For this analysis, we
used iTRAQ data that included peptides that were mapped to multiple
proteins. First, to obtain high quality proteomic data, proteins with
missing values in more than 20% of the samples were excluded from
analyses. Second, expression levels of proteins with missing values in
less than 20% of samples were imputed using the Multivariate Impu-
tation tool “mice” package in R (32).
Analysis of RNA-seq Data—Log2-transformed and normalized
RSEM gene transcript values of RNA-seq data were obtained and
genes with a value of zero in more than 20% of the samples were
excluded from analyses.
Image-mRNA and Image-Protein Correlation Analysis—8125 com-
mon genes that had both the mRNA and protein expression values
were identified. For this subset of genes, the correlations between
image features and expression values (protein and mRNA) of a gene
were calculated using Spearman’s rank correlation ().
Here we chose a relatively loose cutoff of Spearman’s rank corre-
lation coefficient , which corresponds to the p value 0.01. Specif-
ically, we designated   0.3 as correlated whereas   0.3 was
considered uncorrelated.
Validation of the Image-protein Correlation—Besides the CPTAC
data, we used the matched proteome data based on RPPA technol-
ogy of the selected 73 samples for validation. The RPPA proteomic
data after normalization were downloaded and the similar processing
method with MS-based proteomic data was applied. The Spearman
correlation coefficients between image features and protein levels
measured using RPPA technology was calculated. The correlations
for image-RPPA and image-CPTAC data were then compared.
Biological Process Enrichment Analysis—In order to identify en-
riched biological processes associated with images features,
Gene ontology (GO) analyses were performed using ToppGene
(https//topgene.cchmc.org) (33) based on genes whose mRNA or
protein product was correlated with morphological features. Here
only genes correlated with selected morphological features in Table
II were used to perform enrichment analysis. The Fisher’s exact test
TABLE I







Patient No. 73 1,057
PAM50 Subtype Patient No.a
basal-like 18 135
luminal A 22 403




ER Status 49/24 778/232
PR_Status 41/32 674/333





Stage I 8 182
Stage II 48 610
Stage III 16 245







aSome information is missing for certain patients.
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TABLE II
Examples and interpretation of selected morphological features
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was used to calculate p values for gene set enrichment and a false
discovery rate (BH FDR) q value was calculated for multiple test
compensation. Only GO terms with q-values less than 0.05 were
considered significantly enriched.
Survival Analysis—To assess the association between image fea-
tures and patient survival information, for each selected image fea-
ture, the patient cohort was divided into two groups (high image
feature value and low value groups) by applying a cutoff on the image
feature values. Then Kaplan-Meier estimator was used for patient
stratification and log-rank test was adopted to compare the survival
difference between two groups. To choose the best image feature
value cut-off with most significant survival difference, we adopted the
same procedure as the Human Pathology Atlas, which is part of the
Human Proteome Atlas (34). Specifically, all values of the selected
feature were ranked and values from the 20th to 80th percentiles were
used to identify the cutoff for grouping patients, significant differ-
ences in the survival outcomes of the groups were examined and the
value yielding the lowest log-rank p value was selected as the cutoff.
Features were designated as prognostic image features for those with
log-rank p value less than 0.001 for the selected cutoff.
Further, we determined if a prognostic image feature is a “favor-
able” or “unfavorable” feature by applying the univariate Cox propor-
tional hazards regression analysis with the hazard ratio (HR) larger
than 1.2. An unfavorable prognostic image feature was defined as
whose higher value is associated with the poor survival whereas
favorable prognostic image feature has lower value associated with
poor survival.
All analysis above were performed using the “survival” R package
(35).
Morphological Features Associated with Clinical Subtype Classifi-
cation—The associations between each morphological features and
clinical subtype classification (i.e. Basal, Luminal A, Luminal B, Her2)
were examined using Kruskal-Wallis Test.
Statistical Analysis Software—Except where noted above, all sta-
tistical analyses were performed in R version 3.5.1. The analysis




Correlations Analysis Between Multi-omics Data and Mor-
phology—To investigate the relationships between molecular
data and histopathology features, we performed correlation
analysis between imaging features and mRNA or protein (MS-
based global proteomic data) profiles by calculating Spear-
man’s rank correlation coefficients (). A total of 8,125 genes
with both mRNA and protein expression and 100 image fea-
tures for 10 types of cell-level image features extracted from
histopathology images were analyzed. As the processes from
transcriptome to proteome to morphology were quite com-
plex, in order to be comprehensive in identifying potential
molecular basis for different morphological features, corre-
lated image-mRNA or image-protein pairs were designated
using a cutoff of   0.3 to avoid excessive stringency.
The results are summarized in Table III. Among the 100 
8,125  812,500 mage-gene pairs, 5.82% of all image-mRNA
pairs and 3.95% of all image-protein pairs were observed
to be correlated. In addition, 92.96% showed consistent cor-
relative relationships (either correlated or uncorrelated) in
both image-mRNA and image-protein relationships including
0.79% positive correlations, 0.57% negative correlations, and
91.60% no correlation. In contrast, 4.45% image-gene pairs
showed correlations only in the image-mRNA relationship,
whereas 2.58% were only correlated in image-protein pairs.
Opposite image-mRNA and image-protein correlative rela-
tionships (i.e. positive correlation in one pair but negative in
the other) were observed for only 0.003% of all image-gene
pairs. Such globally consistent patterns can also be ob-
served between every image feature and mRNAs and
proteins, regardless of positive or negative correlations as
demonstrated in supplemental Fig. S1. These results sug-
gested that, at the genome scale, image-mRNA and image-
protein shared consistent correlation patterns.
Next, we compared the distribution of correlation coefficients
for image-mRNA and image-protein pairs for individual morpho-
logical features (i.e. Area, Major_Axis, Minor_Axis, Ratio, Mean_
Distance, Max_Distance and Min_Distance). Specifically, we
focused on the selected morphological features in Table II.
The correlation for image feature with most of the proteins
were consistent with matched mRNA. Supplemental Fig. S2
showed the distribution of correlations for image-mRNA and
image-protein for these features. At the individual feature
level, the distribution of correlations for individual image fea-
tures also revealed consistent correlation patterns between
image-mRNA and image-protein pairs.
Comparison of Image-protein Correlation Between CPTAC
and TCGA Data—In order to test whether the correlation
pattern between image-CPTAC measurement overfits the
data, we used the matched proteome data based on RPPA
technology of these 73 samples for validation. Here we com-
pared the correlation patterns between image features and
protein measurements from MS-based technology and RPPA
technology. As shown in Fig. 2 for an example for the Large_
Nucleus_Area feature. We observed overall consistent results
supporting the robustness of correlation between protein pro-
files and morphological features (correlation coefficients range
from 0.472 to 0.597). Results for the rest selected morphological
features were displayed in supplemental Fig. S3.
Image-protein Correlation Analysis Reveals Specific Biolog-
ical Processes Associated with Morphological Features—To
test whether proteomics data can reveal biological processes
associated with morphological features that cannot be in-
ferred from transcriptomic (mRNA) data alone, we compared
TABLE III
The statistics of correlation relationships between morphological fea-





Positive correlation 6438 17463 7
Noncorrelation 11273 744223 9707
Negative correlation 20 18702 4667
Abbreviations: Positive correlation,   0.3; Negative correlation:
  0.3. Non-correlation:   0.3.
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enriched gene ontology (GO) terms obtained from mRNAs
and proteins that showed strong positive correlation with
individual morphological features. After examining these sig-
nificantly enriched GO Biological Process categories associ-
ated with morphological features, we found most of these
Biological Process categories identified based on mRNA
data can be confirmed based on proteomic data except for
Large_Nucleus_Area (implying large nuclei) related biologi-
cal process. However, some unique Biological Process cat-
egories associated with morphological features were found
solely based on proteomics data. For instance, for Small_
Nucleus_Area (implying small nuclei), protein related Biolog-
ical processes such as posttranscriptional regulation of
gene expression and translation were identified from only
proteomics data (supplemental Table S1). Table IV showed
the most significantly enriched biological processes terms
for individual morphological features based on the positive
correlated proteins and mRNAs. In addition, we noticed that
for the feature Large_Nucleus_Area (implying large nuclei),
mitochondria protein synthesis process involving largely the
mitochondrial Ribosomal proteins (MRPs) proteins was sig-
nificantly enriched based on proteomics data, whereas in
contrast it was RNA synthesis process inferred from mRNA
data (Fig. 3). Based on these observations, proteomic data
can reveal biological processes associated with certain
FIG. 2. Validating relationships between morphological feature
and proteomic data using RPPA data with an example (Large_
Nucleus_Area). The correlation coefficient values show consistent
distributions for image-RPPA proteomic data and image-CPTAC pro-
teomic data. Each dot represents an image-gene pair with the x axis
being the correlation coefficient between image-RPPA measurement
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morphological features, which cannot be otherwise identi-
fied from transcriptional data alone.
Specific Biological Processes Associated with Image Fea-
tures—As the genes and proteins correlated with the morpho-
logical features may shed light on the molecular basis for the
cellular and tissue morphology in cancer, gene ontology (GO)
enrichment analysis was performed for proteins correlated
with each individual morphological feature (i.e. Nuclear Area,
Major_Axis, Minor_Axis, Ratio, Mean_Distance, Max_Distance,
and Min_Distance) based on if the proteins were positively or
negatively correlated. In order to identify biological processes
associated with specific types of morphological features, we
focused on the selected features listed in Table II.
Overall, the analysis revealed GO terms related to four
major categories of biology processes including metabolism,
immune process, cell cycle, and extracellular matrix (ECM)
were significantly enriched (FDR  0.05) for morphological
features (as shown Fig. 4, supplemental Fig. S4 and Table V).
Mitochondrial Ribosomal proteins (MRPs) and mRNA proc-
essing related biology processes stood out among metabolic
related GO processes. Although for ECM, cell adhesion, cell
migration, and vascular system development related GO
terms were shared biology processes (Fig. 4 and supplemen-
tal Fig. S4). For positive correlations, both Small_Nucleus_
Area (implying small nuclei) and Small_Major_Axis (implying
small nuclei) were significantly correlated with cell cycle re-
FIG. 3. Significantly enriched GO biological processes for large Nuclei Area based on proteomic and Transcriptomic data. x axis lists
significant enriched biological processes associated with Large_Nucleus_Area. y axis is -log10(FDR). Orange stands for the mitochondria
protein synthesis related biological processes that were identified based on proteomic data. Blue stands for RNA synthesis related biological
processes that were identified based on transcriptomic data. Here only top10 enriched biological processes were listed for each category.
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lated processes and well-known cell cycle related proteins
such as CDCA8, CDC20, NDC80, and BUB1B. In addition,
Small_Nucleus_Area (implying small nuclei), Large_Nucleus_
Area (implying large nuclei), Small_Aspect_Ratio (implying
round nuclei), Small_Major_Axis (implying small nuclei), Large_
Minor_Axis (implying large nuclei), Small_Mean_Distance (im-
plying high cell density), Small_Max_Distance (implying high
cell density), and Small_Min_Distance (implying high cell den-
sity) were all significantly correlated with metabolic pro-
cesses. Among the proteins associated with these pro-
cesses, mammalian mitochondrial ribosomal proteins (i.e.
MRPL9, MRPL21, MRPL39) showed high correlation, which
function in RNA synthesis and processing as well as protein
synthesis and translation in cytosol and/or mitochondria
and are necessary for the fast growth of tumor cells (36).
Although the detailed relationships between cancer cell nu-
clear size and protein expression as well as metabolism
have not been fully investigated, studies based on cancer
cell lines suggested protein synthesis rates are positively
correlated with cell size, which may be related to nuclear
size as well (37).
Moreover, morphological features like Small_Aspect_Ratio
(implying round nuclei) and Small_Mean_Distance (implying
high cell density), were significantly correlated with immune
FIG. 4. Significantly enriched GO biological processes for morphological features based on proteomic data. Only positive correlations
between proteomic data and morphological features were included. Dots represent significantly enriched biological processes based on
Benjamini-Hochberg corrected false discovery rate (‘F.D.R.B.H’) with color coding: purple indicates high enrichment, red indicates low
enrichment.
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processes. This is consistent with our knowledge in pathology
that many lymphocytes can be identified based on their typ-
ical small and round shape (12, 14) as well as densely aggre-
gated patterns. Immune response related proteins such as
FCN1, LY75, and major histocompatibility complex (MHC)
related proteins such as TAP1, TAP2, B2M were among the
ones that are highly correlated with these morphological
features.
Further, features such as Large_Aspect_Ratio (implying
elongated shape), Large_Major_Axis (implying large or elon-
gated nuclei), Small_Minor_Axis (implying small or elongated
nuclei), and Large_Mean_Distance (implying low cell density)
correlated with proteins that are significantly enriched with
ECM development, which is consistent with the development
of tumor stroma in the microenvironment. As stromal cells
such as fibroblasts are typically spindle-shaped with elon-
gated nuclei (12) and sparsely scattered in the stroma, they
are characterized by long major axes and/or large ratio be-
tween major and minor axes and low density compared with
epithelial cells. Collagen related proteins such as COL5A1,
COL5A2 and COL5A3, which are structural constituent of
EMC were identified. From the breast cancer biopsy samples
with immunohistochemical staining for COL5A1 in the Human
Protein Atlas (HPA) database, we indeed observed a high
percentage of stromal cell existing in breast cancer for the
ones with high COL5A1 staining (supplemental Fig. S5). Sim-
ilar results were also observed for MRC2 and COL3A1, which
were also highly correlated with morphological features linked
to stroma cells (supplemental Fig. S5). Together, the associ-
ated biological processes and well-known protein markers
support our understanding of the biological basis of different
cell type morphological features.
Like the positive correlations between proteomic data and
morphological features, such patterns of shared high-level
biological processes were also observed in proteins that are
negatively correlated with morphological features. Because
the values of the image features are relative (i.e. percentages)
based on distribution of the values, most of the enriched
biology processes associated with the selected extremal fea-
tures showed inverse enrichment (i.e. the proteins show pos-
itive correlations with the large feature values often show
negative correlations with the corresponding small aspect).
For negative correlations, metabolic process was shown
to be significantly associated with features including Small_
Nucleus_Area (implying small nuclei), Large_Aspect_Ratio
(implying elongated shape), Small_Major_Axis (implying small
TABLE V
The summary of significantly enriched biology processes for proteins correlated with morphological features based on proteomic data
Morphology feature type Correlation type Morphology feature
Significantly enriched
biological process
Area Positive correlation Small_Nucleus_Area Cell cycle, Metabolic
Large_Nucleus_Area Metabolic
Negative correlation Small_Nucleus_Area Metabolic
Large_Nucleus_Area Immune
Ratio Positive correlation Small_Aspect_Ratio Immune, Metabolic
Large_Aspect_Ratio ECM
Negative correlation Small_Aspect_Ratio ECM
Large_Aspect_Ratio Metabolic
Major_axis Positive correlation Small_Major_Axis Cell cycle, Metabolic
Large_Major_Axis ECM
Negative correlation Small_Major_Axis Metabolic
Large_Major_Axis Metabolic
Minor_axis Positive correlation Small_Minor_Axis ECM
Large_Minor_Axis Metabolic
Negative correlation Small_Minor_Axis Metabolic
Large_Minor_Axis TME,Immune
Max_distance Positive correlation Small_Max_Distance Immune, Metabolic
Large_Max_Distance ECM
Negative correlation Small_Max_Distance ECM
Large_Max_Distance Immune, Metabolic
Min_distance Positive correlation Small_Min_Distance Immune, Metabolic
Large_Min_Distance ECM
Negative correlation Small_Min_Distance TME, Metabolic
Large_Min_Distance Immune, Metabolic
Mean_distance Positive correlation Small_Mean_Distance Immune, Metabolic
Large_Mean_Distance ECM
Negative correlation Small_Mean_Distance ECM
Large_Mean_Distance Immune, Metabolic
Note: ECM related biology processes includes: extracellular matrix (ECM), cell adhesion, cell migration, and vascular system GO functions;
Metabolic related biology process mostly include: Mitochondrial Ribosomal proteins (MRPs) and mRNA processing related GO functions.
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nuclei), Large_Major_Axis (implying large or elongated nuclei),
Small_Minor_Axis (implying small or elongated nuclei),
Large_Mean_Distance (implying low cell density), Large_
Max_Distance (implying low cell density), Small_Min_Distance
(implying high cell density), and Large_Min_Distance (implying
low cell density). Immune processes were significantly en-
riched in proteins negatively correlated with features such as
Large_Nucleus_Area (implying large nuclei), Large_Minor_Axis
(implying large nuclei), Large_Mean_Distance (implying low cell
density), Large_Max_Distance (implying low cell density), and
Large_Min_Distance (implying low cell density). The ECM re-
lated features were significantly enriched in Small_Aspect_
Ratio (implying round nuclei), Large_Minor_Axis (implying
large nuclei), Small_Mean_Distance (implying low cell den-
sity), Small_Max_Distance (implying low cell density), and
Small_Min_Distance (implying low cell density) (Table V and
supplemental Fig. S4).
In summary, four major types of biology process including
metabolism, immune, cell cycle and ECM development were
identified based on proteomic data because of strong asso-
ciations with morphological features.
Survival Analysis Based on the Morphological Features—
Because morphological parameters extracted from histopa-
thology images are essential for breast cancer diagnosis
and prognosis by pathologists, we also investigated how
well these morphological features are associated with clin-
ical outcome of the patients as described in the Methods
section to assess the association between morphological
feature and patient overall survival information for all the
1,057 patients in the TCGA BRCA project. Morphological
features (p value  0.001, HR  1.2) associated with both
favorable and unfavorable prognosis have been identified
using the workflow described above. In Fig. 5, examples of
favorable and unfavorable prognostic morphological fea-
tures were shown, based on the optimal stratification p
value calculated using a similar approach as in (34) (detailed
information for other morphological features were provided
in supplemental Fig. S6). Five prognostic morphological
features that were strongly correlated with patients’ overall
survival were selected (Fig. 6). After examining these sur-
vival-associated variables, we found unfavorable prognostic
morphological features including Large_Nucleus_Area (im-
plying large nuclei), Large_Minor_Axis (implying large or
elongated nuclei), and Large_Max_Distance (implying low
cell density). These morphological features were linked to
large cell nuclei or large distances to neighboring cells,
which were highly associated with metabolic or ECM related
biology processes (Table VI). As for favorable prognostic
FIG. 5. Identification of prognostic
morphological features based on
morphological feature values cou-
pled with survival information for
breast cancer. Left: Distribution of p
values of log-rank tests against the im-
age feature values with different cut-
offs. Right: Kaplan-Meier curves for
morphological feature based on the
best cutoff. A, Example of an unfavor-
able prognostic morphological feature;
B, example of a favorable prognostic
morphological feature.
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morphological feature, they tended to be small distances to
neighboring cells (Small_Mean_Distance and Small_Min_
Distance), which were highly correlated with metabolic or
immune related processes (Table VI).
Morphological Features Significantly Associated with Clini-
cal Subtype Classification—As breast patients can be cate-
gorized into subtypes including Basal, Luminal A, Luminal B,
Her2 type based on histology and molecular signatures, we
performed Kruskal-Wallis Test for each selected image fea-
ture to test if they have significant associations with these
clinical subtypes. All the image features exhibit significant
differences between breast cancer subtypes except for
Small_Minor_Axis (supplemental Table S2). These results are
consistent with the fact that morphological features are criti-
cal to guide diagnosis and treatment.
DISCUSSION
Solid tumors such as breast cancer are highly heterogene-
ous, with multiple types of cells such as epithelial cells, im-
mune cells and other stromal cells. Given the importance of
tumor morphological features in diagnosis and prognosis,
investigating the relationship between the molecular data and
morphology can lead to potential new insight on the molecular
basis underlying cancer development and prognosis. Taking
advantage of the computational pathology workflow we es-
tablished for processing whole slide images, we were able to
extract quantitative morphological features from histopathol-
ogy slides of breast cancer tissues, thus enabling investigat-
ing relationships between tumor tissue morphology and om-
ics data. In addition, because mRNA and protein data contain
related but different levels of molecular information, integrat-
ing both data with morphological features can lead to discov-
ery of different biological events associated with cancer tissue
morphology.
Based on the correlation analysis between morphological
features derived from whole slide images of tissue samples
and molecular data (mRNA or proteomic data), four major
types of biology processes, namely metabolic, cell cycle,
immune, and ECM development processes have been identi-
fied. These processes have all been strongly associated with
cancer hallmarks (6). Morphological features enriched with met-
abolic and cell cycle processes were associated with cancer
(epithelial) cells. Among these metabolic processes, we ob-
served strong signals for mitochondria related biology pro-
cesses, the protein translational process related to mitochon-
drial Ribosomal proteins (MRPs). Kim et al. (36) previously
demonstrated the important function of MRPs in regulating
apoptosis, cell cycle, and cell proliferation. As for cell cycle
processes, Yuan et al. have highlighted its close relationship
with cancer morphologic features (12). However, although it is
often anticipated that active cell cycle progress may be as-
sociated with large nuclei because of chromosome duplica-
tion and mitosis, our results suggest that they may also lead
to more smaller cells in breast cancer possibly because of
active division even though the detailed mechanism calls for
future in-depth investigation. In addition, ECM development
and immune response processes for tumor microenvironment
were associated with stromal cells and tumor infiltrating lym-
phocytes respectively (38–41). We found that these stromal
cells related features are most strongly associated with tumor
microenvironment (TME) development (e.g. ECM, cell adhe-
sion, cell migration). Previous studies have demonstrated that
the interaction between stromal cells (such as cancer-asso-
ciated fibroblasts, a typical stroma cell) and ECM has a crucial
role in tumor initiation, progression, and metastasis (42–44),
which is an important hallmark of cancers. Beck et al. previ-
ously demonstrated the importance of TME related morpho-
logical features in breast cancer prognosis (22) and our results
linked related features to the potential underlying genes. In
addition, cancer-associated fibroblast (CAF) is a typical stro-
mal cell and can recruit and bind collagen fibers (key compo-
nents of ECM) thus convert a loose stroma into a dense
stromal network (43, 44), this network acts as a barrier to drug
flow, thereby increasing chemoresistance. Lastly, Yuan et al.
also identified that immune related pathways were correlated
with the lymphocyte morphologic features (12), which is con-
sistent with our observation. Taken together, our approach
can identify the specific biological process associated with
individual morphological features. These results not only con-
firm our understanding of the molecular basis of morphology,
but also offer new insights and hypotheses regarding the
development of cancer tissues for future investigation.
When comparing the significantly enriched biological pro-
cesses associated with morphological features based on
mRNA and protein, we found that although most of the sig-
nificantly enriched biological process categories were similar,
some unique biological processes associated with morpho-
logical features were identified only based on proteomics data
FIG. 6. Forest plot for morphological features to predict the
overall survival (OS) of breast cancer. Abbreviations: HR  hazard
ratio; CI  confidence interval.
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(e.g. posttranscriptional related biological processes). In ad-
dition, the mitochondria-related metabolism processes also
stood out based on proteomic data. Latonen et al. recently
showed that post-transcriptional events take important roles
in the mitochondria during cancer progression (45). These
results strongly suggest that proteomic data are important in
fully characterizing the molecular events associated with mor-
phological changes at cellular and tissue levels and are im-
portant for understand the development of cancers.
Because histopathology images are essential for cancer
diagnosis and prognosis, we also identified favorable and
unfavorable prognostic morphological features and the cor-
responding biological process associated with them. Among
these unfavorable predictors, large values of long distance to
adjacent nuclei imply a high percentage of stromal compo-
nents in the in whole-slide images. Yuan et al. and Beck et al.
both demonstrated that stromal morphologic structure is an
important prognostic factor in breast cancer, patients with
higher stromal proportions had worse prognosis than other
patients (12, 22). In addition, we also observed that large
nuclear area is associated with poor survival. Previous studies
have highlighted that cancer cells with enlarged nuclei almost
always indicate more aggressive outcomes (46). Currently,
anti-estrogen therapy to decreased nuclear size in tumors are
used for preoperative treatment of breast cancer patients (46).
As for favorable predictors, most of them were related to
immune responses, suggesting that activation of immune sys-
tem plays critical roles in fighting cancer, which are consistent
with many recent studies on cancer immunology and immu-
notherapy (12, 47, 48).
Despite the extensive observations and results generated
from our analysis, some limitations of this study should be
noticed as well. First, the key molecular regulators for the cell
type morphology features were still unknown, even though the
associated biological processes were inferred because our
current study focuses on correlation analysis instead of
causal analysis. Deeper analysis for the regulatory and driver
genes and proteins using more sophisticated statistical meth-
ods combined with experimental validation will be carried out
soon. Second, we only included 73 breast cancer patients for
the correlation analysis between molecular data and morphol-
ogy phenotypes in this study because of the limitation of
available data. The image-protein and image-mRNA relation-
ships identified here may not represent all breast cancer
subtypes. Despite that the correlative relationships between
proteomic data and morphology were validated using
matched RPPA data, further confirmation using independent
datasets is still needed despite the lack of such data at the
meantime. Last but not the least, even though we showed that
the cell nucleic features suggested stromal or tumor cells, it is
difficult to distinguish different cell types accurately just based
on the nucleic morphology alone.
In summary, we carried out a unique systematic study on the
relationship between tumor tissue morphology and transcrip-
tomic as well as proteomic data in breast cancer. We observed
concordant distribution patterns of correlation coefficients be-
tween image-mRNA and image-protein at the genome scale.
Four major types of important biological processes related to
cancers have been associated with various morphological fea-
tures. Importantly, proteomic data are critical in identifying pro-
tein related biological processes associated with morphological
features, which cannot be captured by transcriptomic data. In
addition, morphological features associated with patient sur-
vival have been identified and their underlying molecular pro-
cesses based on the associated proteins can link these mor-
phological features to different hallmarks of cancers.
In conclusion, our analysis demonstrated the potential for
integrating morphological information and molecular data for
generating new biological hypothesis for cancer research. The
algorithmic development for computational pathology un-
leashes the potential for similar large-scale studies for differ-
ent cancers. More sophisticated modeling and integration
methods will lead to deeper understanding of the regulation of
the tissue morphology and importance of protein in this proc-
ess, contributing to the generation of new insights for cancer
biology and outcome prediction.
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public sources. Proteomic data were accessed from the NCI
CPTAC Data Portal. Histopathology images were downloaded
directly through the NCI GDC TCGA Data Portal, whereas
transcriptomic data were downloaded from the UCSC Xena
data portal (https://xena.ucsc.edu/public-hubs/). Matched
RPPA proteomic data were obtained from the Broad GDAC
TABLE VI
Summary of survival-associated morphological features
Morphology feature p value Prognostic type Associated biology process
Large_Nucleus_Area 2.96E-09 unfavorable prognostic Metabolic
Large_Minor_Axis 6.11E-05 unfavorable prognostic Metabolic
Large_Max_Distance 9.71E-05 unfavorable prognostic ECM
Small_Mean_Distance 0.51E-03 favorable prognostic Immune, Metabolic
Small_Min_Distance 6.55E-06 favorable prognostic Immune, Metabolic
Note: p value formatting as the following example: 2.96E-09 is 0.00000000296.
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Firehose (https://gdac.broadinstitute.org). cell morphological
features and patient survival outcomes, 1,057 BRCA-type
breast patients with matched 1057 H&E-stained tissue im-
ages and corresponding clinical survival information were
used. The patient clinical data were obtained from UCSC
Xena. The analysis scripts that we used for this manuscript
are available at GitHub: https://github.com/xiaohuizhan/
cor_image_omics_BRCA.
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16. Wang, C., Pécot, T., Zynger, D. L., Machiraju, R., Shapiro, C. L., and Huang,
K. (2013) Identifying survival associated morphological features of triple
negative breast cancer using multiple datasets. J. Am. Med. Inform.
Assoc. 20, 680–687
17. Cooper, L. A., Kong, J., Gutman, D. A., Wang, F., Gao, J., Appin, C.,
Cholleti, S., Pan, T., Sharma, A., Scarpace, L., Mikkelsen, T., Kurc, T.,
Moreno, C. S., Brat, D. J., and Saltz, J. H. (2012) Integrated morphologic
analysis for the identification and characterization of disease subtypes.
J. Am. Med. Inform. Assoc. 19, 317–323
18. Patey, D. H., and Scarff, R. W. (1928) The Position of Histology in the
Prognosis of Carcinoma of the Breast. Lancet 211, 801–804
19. Yuan, Y. Y. (2016) Spatial heterogeneity in the tumor microenvironment.
Cold Spring Harbor Perspect. Med. 6, pii: a026583
20. Cheng, J., Mo, X., Wang, X., Parwani, A., Feng, Q., and Huang, K. (2018)
Identification of topological features in renal tumor microenvironment
associated with patient survival. Bioinformatics 34, 1024–1030
21. Wang, C., Machiraju, R., and Huang, K. (2014) Breast cancer patient
stratification using a molecular regularized consensus clustering method.
Methods 67, 304–312
22. Beck, A. H., Sangoi, A. R., Leung,, S., Marinelli, R. J., Nielsen, T. O., van de
Vijver, M. J., West, R. B., van de Rijn, M., and Koller, D. (2011) Systematic
analysis of breast cancer morphology uncovers stromal features asso-
ciated with survival. Sci. Transl. Med. 3, 108–113
23. Yuan, Y. Y., Failmezger, H., Rueda, O. M., Ali, H. R., Graf, S., Chin, S. F.,
Schwarz, R. F., Curtis, C., Dunning, M. J., Bardwell, H., Johnson, N.,
Doyle, S., Turashvili, G., Provenzano, E., Aparicio, S., Caldas, C., and
Markowetz, F. (2012) Quantitative image analysis of cellular heterogene-
ity in breast tumors complements genomic profiling. Sci. Trans. Med. 4,
157ra143
24. Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R.,
Kibbe, W. A., and Staudt, L. M. (2016) Toward a shared vision for cancer
genomic data. New Engl. J. Med. 375, 1109–1112
25. The Cancer Genome Atlas, N., Koboldt, D. C., Fulton, R. S., McLellan, M. D.,
Schmidt, H., Kalicki-Veizer, J., McMichael, J. F., Fulton, L. L., Dooling, D. J.,
Ding, L., Mardis, E. R., Wilson, R. K., Ally, A., Balasundaram, M., Butterfield,
Y. S. N., Carlsen, R., Carter, C., Chu, A., Chuah, E., Chun, H.-J. E., Coope,
R. J. N., Dhalla, N., Guin, R., Hirst, C., Hirst, M., Holt, R. A., Lee, D., Li, H. I.,
Mayo, M., Moore, R. A., Mungall, A. J., Pleasance, E., Gordon Robertson,
A., Schein, J. E., Shafiei, A., Sipahimalani, P., Slobodan, J. R., Stoll, D.,
Tam, A., Thiessen, N., Varhol, R. J., Wye, N., Zeng, T., Zhao, Y., Birol, I.,
Jones, S. J. M., Marra, M. A., Cherniack, A. D., Saksena, G., Onofrio, R. C.,
Pho, N. H., Carter, S. L., Schumacher, S. E., Tabak, B., Hernandez, B.,
Gentry, J., Nguyen, H., Crenshaw, A., Ardlie, K., Beroukhim, R., Winckler,
W., Getz, G., Gabriel, S. B., Meyerson, M., Chin, L., Park, P. J., Kucher-
lapati, R., Hoadley, K. A., Todd Auman, J., Fan, C., Turman, Y. J., Shi, Y.,
Li, L., Topal, M. D., He, X., Chao, H.-H., Prat, A., Silva, G. O., Iglesia, M. D.,
Zhao, W., Usary, J., Berg, J. S., Adams, M., Booker, J., Wu, J., Gulabani,
A., Bodenheimer, T., Hoyle, A. P., Simons, J. V., Soloway, M. G., Mose,
L. E., Jefferys, S. R., Balu, S., Parker, J. S., Neil Hayes, D., Perou, C. M.,
Malik, S., Mahurkar, S., Shen, H., Weisenberger, D. J., Triche Jr, Lai,
T. P. H., Bootwalla, M. S., Maglinte, D. T., Berman, B. P., Van Den Berg,
D. J., Baylin, S. B., Laird, P. W., Creighton, C. J., Donehower, L. A., Getz,
G., Noble, M., Voet, D., Saksena, G., Gehlenborg, N., DiCara, D., Zhang, J.,
Zhang, H., Wu, C.-J., Yingchun Liu, S., Lawrence, M. S., Zou, L., Si-
vachenko, A., Lin, P., Stojanov, P., Jing, R., Cho, J., Sinha, R., Park, R. W.,
Nazaire, M.-D., Robinson, J., Thorvaldsdottir, H., Mesirov, J., Park, P. J.,
Chin, L., Reynolds, S., Kreisberg, R. B., Bernard, B., Bressler, R., Erkkila, T.,
Lin, J., Thorsson, V., Zhang, W., Shmulevich, I., Ciriello, G., Weinhold, N.,
Schultz, N., Gao, J., Cerami, E., Gross, B., Jacobsen, A., Sinha, R., Arman
Aksoy, B., Antipin, Y., Reva, B., Shen, R., Taylor, B. S., Ladanyi, M., Sander,
C., Anur, P., Spellman, P. T., Lu, Y., Liu, W., Verhaak, R. R. G., Mills, G. B.,
Akbani, R., Zhang, N., Broom, B. M., Casasent, T. D., Wakefield, C., Unruh,
A. K., Baggerly, K., Coombes, K., Weinstein, J. N., Haussler, D., Benz,
C. C., Stuart, J. M., Benz, S. C., Zhu, J., Szeto, C. C., Scott, G. K., Yau, C.,
Correlative Analysis of Proteomic and Image Data for BRCA
S50 Molecular & Cellular Proteomics 18.14
Paull, E. O., Carlin, D., Wong, C., Sokolov, A., Thusberg, J., Mooney, S., Ng,
S., Goldstein, T. C., Ellrott, K., Grifford, M., Wilks, C., Ma, S., Craft, B., Yan,
C., Hu, Y., Meerzaman, D., Gastier-Foster, J. M., Bowen, J., Ramirez, N. C.,
Black, A. D., Pyatt, R. E., White, P., Zmuda, E. J., Frick, J., Lichtenberg,
T. M., Brookens, R., George, M. M., Gerken, M. A., Harper, H. A., Leraas,
K. M., Wise, L. J., Tabler, T. R., McAllister, C., Barr, T., Hart-Kothari, M.,
Tarvin, K., Saller, C., Sandusky, G., Mitchell, C., Iacocca, M. V., Brown, J.,
Rabeno, B., Czerwinski, C., Petrelli, N., Dolzhansky, O., Abramov, M.,
Voronina, O., Potapova, O., Marks, J. R., Suchorska, W. M., Murawa, D.,
Kycler, W., Ibbs, M., Korski, K., Spychała, A., Murawa, P., Brzeziński, J. J.,
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